Performing Department
(N/A)
Non Technical Summary
The Society for In Vitro Biology's (SIVB) 2025 annual meeting will focus on the latest developments, core fundamentals and associated risks of applying in vitro biotechnology and genomics in both plants and animals. The meeting will bring together researchers from leading university, industry, and government labs to convey new knowledge, foster collaborations and move plant and animal biotechnology forward. The focus is on novel methods for transgene delivery, application of genome editing and epigenetic modification, risk assessment of novel biotechnology approaches and transgenic products and development and implementation of effective gene containment strategies. The 2005 meeting will be held on June 7-10, 2025, at the Hilton "The Main", Norfolk, Virginia. Plenary sessions will focus on innovative approaches for plant and animal transformation, plant and animal genome engineering, environmental risk assessment of GE organisms, the use of genome editing, and new advances in development of novel gene containment strategies. These themes are further developed in numerous animal- and plant-focused symposia as well as education symposia and workshops with a focus on student involvement. Speaker and poster abstracts will be published in the SIVB journals. Selected sessions will be recorded and made available through an Online Limited Access Program. Funds are requested for student and speaker support as well as costs of running the meeting. The meeting will provide a venue for sharing recent scientific advancements in this field leading to outreach and the education of the public on biotechnologies for gene modification to benefit plant and animal agriculture. ?
Animal Health Component
(N/A)
Research Effort Categories
Basic
(N/A)
Applied
(N/A)
Developmental
(N/A)
Goals / Objectives
The overall goal of the 2025 Society for In Vitro Biology Meeting is to bring attendees from academia, industry, and government together to foster communication and research, to advance the science of biotechnology as applied to both plants and animals and to promote interactions with and education of governmental regulators and the general public. The outcome of the conference is the dissemination of science-based information on the use of genetic engineering and gene editing in plants and animals and any associated risks. More specifically, the current conference grant seeks to provide attendees of the 2025 Society for In Vitro Biology Meeting with the most current advances in the development of novel plant and animal transformation approaches, transformation processes optimization, and innovations in gene editing tools development and delivery improvement for enhanced genome modification as well as associated potential risks, regulation, and mitigation. The discussion of these important topics will help facilitate productive and safe development of genetically engineered, and genome-edited crops, woody and ornamentals, and animals, producing healthy and environmentally friendly transgenic products for enhanced agriculture production. The specific objectives for this grant are to present and discuss 1) innovative approaches for plant and animal transformation and transformation processes optimization, 2) plant and animal genome engineering including model, non-model and polyploid species, and 3) assessment and mitigation of environmental and human health risks associated with various genetic engineering technologies, especially gene editing, and future regulatory pathways. Furthermore, we plan to enhance outreach to support minority and underserved students and scientists by offering reduced cost registration and virtual opportunities to access the content.
Project Methods
The 2025 In Vitro Biology Meeting will offer symposia with the goal to share the most current information on novel methods for transgene delivery, application of genome editing and epigenetic modification, risk assessment of novel biotechnology approaches and transgenic products and development and implementation of effective gene containment strategies. The 2025 In Vitro Biology Meeting will feature a keynote speaker with 5 plenary/joint sessions, 11 plant biotechnology-focused and 6 animal-focused symposia as well as education symposia and workshops inviting 65-70 speakers. Speakers are scientists from the leading university, government, and industry laboratories in the world who will share their perspective, experience, and knowledge in the above topics. While the specifics are still being worked out, we have information about the plenary session and a panel discussion on biotechnology risk assessment, "Biosafety and gene containment in transgenic plants and animals". The session will be convened by Dr. Hong Luo (Clemson University), Dr. Allan Wenck (Syngenta), Dr. Pierluigi Barone (Corteva Agriscience). The five invited speakers are experts in biotechnology risk assessment research focusing on plants, livestock, and fishes. This plenary session will be followed by a panel discussion on "The role of regulations on the development of and stewardship of transgenic plants and animals", which will be convened by Dr. Raymond D. Shillito from the Shillito & Associates, LLC and participated by five invited panelists from public institutes, industries, and government agencies.